A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders

ConditionsPanic Disorder With Agoraphobia Panic Disorder Without Agoraphobia Generalized Anxiety Disorder Social Anxiety Disorder

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorCharite University, Berlin, Germany

About this trial

The project's aim is to investigate the effect of a transdiagnostic, self-guided, internet-based cognitive behavioral therapy program in waitlist patients with anxiety disorders.

Eligibility criteria

Qualifiers

Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder

Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires

Written informed consent

Internet access

Disqualifiers

Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder)

Acute suicidality

Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)

Trial design

Treatments tested in this trial

Velibra

Treatment groups

30 Participants

are divided into 1 treatment group

Locations

Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin10117, Berlin Germany

Sponsors and collaborators

Charite University, Berlin, Germany

Lead sponsor

Source ClinicalTrials.gov